United States · FDA National Drug Code directory
Fludeoxyglucose F 18
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24562-001_fc81c6d7-e5da-4d87-8acb-5c7380c75efd
- Product NDC
- 24562-001
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Fludeoxyglucose F-18
- Labeler
- Biomedical Research Foundation of Northwest Louisiana
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150514
- Source listing expiry
- 20271231
Source-listed ingredients
- FLUDEOXYGLUCOSE F-18 — 300 mCi/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 mL in 1 VIAL, GLASS (24562-001-30) · 24562-001-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →